Literature DB >> 6995093

Use of levamisole in viral infections.

A S Russell.   

Abstract

Recrudescent herpes simplex infections and common warts are associated with evidence of immune depression. It was hoped that levamisole, a drug with immunomodulatory effects, would be helpful in both prophylaxis and therapy of these diseases. Despite enthusiasm from 'pilot' studies, properly carried out trials showed no benefit from levamisole as compared with a placebo. There is no good evidence for its efficacy in any other viral infection, but proper studies are still lacking.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995093     DOI: 10.2165/00003495-198020020-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

Review 1.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

2.  Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.

Authors:  R J O'Reilly; A Chibbaro; E Anger; C Lopez
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

3.  Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.

Authors:  A K Lee; M Eisinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis.

Authors:  A S Russell; E Brisson; M Grace
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

5.  Letter: Levamisole for warts.

Authors:  P Helin; M Bergh
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

6.  Failure of levamisole in herpes simplex.

Authors:  K A Mehr; L Albano
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

7.  Levamisole in prevention of recurrent upper-respiratory-tract infections in children.

Authors:  M Van Eygen; P Y Znamensky; E Heck; I Raymaekers
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

8.  Immunopotentiation and antiviral chemotherapy in a suckling rat model of herpesvirus encephalitis.

Authors:  G W Fischer; M W Balk; M H Crumrine; J W Bass
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

9.  Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.

Authors:  S Haahr; L Rasmussen; T C Merigan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Levamisole in a double-blind study: no effect on warts.

Authors:  M Schou; P Helin
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

View more
  1 in total

1.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.